Which medication commonly induces sweating (sudation) during a medical termination of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Misoprostol is the Drug That Causes Sudation (Sweating) in Medical Termination of Pregnancy

Misoprostol, a prostaglandin E1 analog, is the medication responsible for inducing sweating and other thermoregulatory side effects during medical abortion. This occurs as part of a constellation of prostaglandin-related symptoms including transient chills and fever 1.

Mechanism and Clinical Presentation

Misoprostol causes sudation through its prostaglandin-mediated effects on thermoregulation. The most recent 2025 Society of Family Planning guidelines clearly document that:

  • Transient pyrexia (fever) occurs in 5-10% of patients receiving misoprostol 1
  • The fever is accompanied by chills and sweating as part of the body's thermoregulatory response
  • These symptoms are transient and resolve within several hours of stopping misoprostol 1

Dose and Route-Dependent Effects

The intensity of sudation and fever varies based on:

  • Administration route: Vaginal misoprostol may result in higher transient fever rates compared to sublingual administration 1
  • Cumulative dose: Higher total doses increase the frequency of side effects 1
  • Individual dose: Both 400 mcg and 600 mcg doses can cause these symptoms 1

Critical Clinical Distinction

A crucial pitfall is distinguishing prostaglandin-induced fever from infection. The guidelines emphasize:

  • Fever from misoprostol is transient and resolves within several hours of stopping the medication
  • A fever persisting for several hours after misoprostol administration should raise concern for possible infection 1
  • Clinicians must maintain a high index of suspicion for infection and treat appropriately, given the morbidity associated with untreated infection
  • Evaluation should include clinical and laboratory assessment and/or judicious antibiotic use 1

Mifepristone Does NOT Cause Sudation

In contrast, mifepristone (the progesterone antagonist used in combination regimens) is not associated with sweating or fever. Its side effects are limited to vaginal bleeding, uterine cramping, and headaches 1. In fact, adding mifepristone to prostaglandin regimens may actually lower nausea and vomiting rates compared to prostaglandin alone 1.

References

Related Questions

How should a public health audit be performed for a patient’s epidemiologic event to determine its origin, cause, and effect?
What are the basic principles of cancer chemotherapy, including drug selection, dosing schedules, combination strategies, dose intensity, monitoring, and supportive care?
What are the possible causes of a pinkish cast to vision in a 65-year-old woman?
What is the appropriate acute management for aldrin poisoning?
What is the likely cause of bleeding gums, a bubble sensation in the left ear, and throbbing pain in front of the left ear that improves with pressure?
What is the recommended dosage of Proplex (human factor IX complex) for treating an acute bleeding episode in an adult with hemophilia B?
Which drug can be used to induce sweating in a multiple trauma patient (MTP)?
What medication should be prescribed for a 15-year-old with substance use disorder, currently on Abilify (aripiprazole) 2 mg and Lexapro (escitalopram) 20 mg, who is irritable in an inpatient psychiatric setting?
For a 70‑kg patient with an INR of 2.2, how much Proplex (prothrombin complex concentrate) should be administered?
Which uterotonic medication should be given after dilation and curettage to promote uterine contraction and reduce bleeding?
What is the recommended next step in managing a 15‑year‑old with an active substance‑use disorder who is taking aripiprazole 2 mg daily and escitalopram 20 mg daily and presents with persistent mood destabilization, depression, and anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.